A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors

Clinical trial NCT07584226 · RECRUITING

Trial details

NCT number: NCT07584226
Sponsor: Relay Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced NRAS-Mutant Melanoma Advanced NRAS-Mutant Solid Tumors NRAS Mutation NRAS G12D NRAS G13R NRAS G13D NRAS G12V NRAS Q61R NRAS Q61K NRAS Q61L NRAS Q61H

Start date: 2026-03-09
Primary completion: 2027-12-30
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.